Skip to main content
Top
Published in: Annals of Surgical Oncology 10/2010

01-10-2010 | Head and Neck Oncology

Importance of Age as a Prognostic Factor for Tonsillar Carcinoma

Authors: Nam P. Nguyen, MD, Bevan Hong Ly, MD, Michael Betz, MD, Vincent Vinh-Hung, MD

Published in: Annals of Surgical Oncology | Issue 10/2010

Login to get access

Abstract

Background

We would like to evaluate the prognostic significance of young age (defined as 50 years old or less) for tonsillar carcinoma because of its association with HPV 16 virus infection.

Materials and Methods

Data were extracted from the SEER database for 5535 patients aged 22–99 years (median 58) diagnosed with squamous cell carcinoma of the tonsil between 1974 and 2003. Primary therapy included radiotherapy for 4494 patients, and surgery for 3018 patients. Cox proportional hazard models were used for cancer-specific survival (CSS) analysis adjusting for demographic characteristics, tumor stage, and local therapy. Subgroups were compared using interaction tests.

Results

The incidence of tonsil carcinoma increased at a faster pace in young patients, from 15% in 1974–1983 to 55% in 1994–2003, compared with an increase from 26% to 37% in older patients. The 5- and 10-year CSS were 74% and 67%, 59% and 46% for young and older patients, respectively. In multivariate analysis, young age was independently associated with 40% relative better CSS compared with older age, hazard ratio 0.60 (95% confidence interval 0.54–0.67).

Conclusion

Young age is associated with an excellent prognosis most likely related at least in part to a higher incidence in this age group of HPV-associated tumors, possibly with increased tumor sensitivity to radiation. Prospective studies on oropharyngeal cancers should be performed to confirm this hypothesis.
Literature
1.
go back to reference Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000;11:489–95.CrossRefPubMed Frisch M, Hjalgrim H, Jaeger AB, Biggar RJ. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control. 2000;11:489–95.CrossRefPubMed
2.
go back to reference Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125:362–6.CrossRefPubMed Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125:362–6.CrossRefPubMed
3.
go back to reference Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, et al. The incidence of tonsillar cancer in Sweden is rising. Acta Otolaryngol 2007;127:988–92.CrossRefPubMed Hammarstedt L, Dahlstrand H, Lindquist D, Onelov L, Ryott M, Luo J, et al. The incidence of tonsillar cancer in Sweden is rising. Acta Otolaryngol 2007;127:988–92.CrossRefPubMed
4.
go back to reference Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinoma in men. Arch Otolaryngol Head Neck Surg. 2009;135:402–5.CrossRefPubMed Sikora AG, Morris LG, Sturgis EM. Bidirectional association of anogenital and oral cavity/pharyngeal carcinoma in men. Arch Otolaryngol Head Neck Surg. 2009;135:402–5.CrossRefPubMed
5.
go back to reference Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev. 2000;9:433–7.CrossRefPubMed Hemminki K, Dong C, Frisch M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev. 2000;9:433–7.CrossRefPubMed
6.
go back to reference El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of palatine tonsil, and not the oral cavity in young patients. Am J Surg Pathol. 2003;27:1463–70.CrossRefPubMed El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of palatine tonsil, and not the oral cavity in young patients. Am J Surg Pathol. 2003;27:1463–70.CrossRefPubMed
7.
go back to reference Li W, Thompson CH, Cossart YE, O’Brien CJ, McNeal EB, Scolyer RA, et al. The expression of key cell cycle markers and the presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck. 2004;26:1–9.CrossRefPubMed Li W, Thompson CH, Cossart YE, O’Brien CJ, McNeal EB, Scolyer RA, et al. The expression of key cell cycle markers and the presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck. 2004;26:1–9.CrossRefPubMed
8.
go back to reference Hammardstedt L, Lindquist D, Dalhlstrand H, Romanitan M, Onelov L, Joneberg G, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–3.CrossRef Hammardstedt L, Lindquist D, Dalhlstrand H, Romanitan M, Onelov L, Joneberg G, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer. 2006;119:2620–3.CrossRef
9.
go back to reference Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Freneaux P, et al. Two types of squamous cell carcinoma of the palatine fossa characterized by distinct etiology, molecular features and outcome. Cancer Lett. 2007;260:72–8.CrossRefPubMed Charfi L, Jouffroy T, de Cremoux P, Le Peltier N, Thioux M, Freneaux P, et al. Two types of squamous cell carcinoma of the palatine fossa characterized by distinct etiology, molecular features and outcome. Cancer Lett. 2007;260:72–8.CrossRefPubMed
10.
go back to reference Chung YL, Lee MY, Horng CF, Jian JJM, Cheng SH, Tsai SY, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiation alone. Head Neck. 2009;31:9–20.CrossRefPubMed Chung YL, Lee MY, Horng CF, Jian JJM, Cheng SH, Tsai SY, et al. Use of combined molecular biomarkers for prediction of clinical outcomes in locally advanced tonsillar cancers treated with chemoradiation alone. Head Neck. 2009;31:9–20.CrossRefPubMed
11.
go back to reference Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffman TK, et al. Combined analysis of HPV-DNA, p16, and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731–8.CrossRefPubMed Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffman TK, et al. Combined analysis of HPV-DNA, p16, and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120:1731–8.CrossRefPubMed
12.
go back to reference Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol. 2008;21:376–86.CrossRefPubMed Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol. 2008;21:376–86.CrossRefPubMed
13.
go back to reference D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behavior associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–9.CrossRefPubMed D’Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behavior associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199:1263–9.CrossRefPubMed
14.
go back to reference Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, et al. Squamous cell carcinoma of the oropharynx: surgery, radiotherapy, or both. Cancer. 2002;94:2967–80.CrossRefPubMed Parsons JT, Mendenhall WM, Stringer SP, Amdur RJ, Hinerman RW, Villaret DB, et al. Squamous cell carcinoma of the oropharynx: surgery, radiotherapy, or both. Cancer. 2002;94:2967–80.CrossRefPubMed
15.
go back to reference Li W, Thompson CH, O’Brien CJ, McNeil EB, Scolyer RA, Cossart YE, et al. Human papillomavirus positivity predicts favorable outcome for squamous cell carcinoma of the tonsil. Int J Cancer. 2003;106:553–8.CrossRefPubMed Li W, Thompson CH, O’Brien CJ, McNeil EB, Scolyer RA, Cossart YE, et al. Human papillomavirus positivity predicts favorable outcome for squamous cell carcinoma of the tonsil. Int J Cancer. 2003;106:553–8.CrossRefPubMed
16.
go back to reference Cohen MA, Basha SR, Reichenbach DK, Robertson E, Sewell DA. Increased viral load correlates with improved survival in HPV-16 associated tonsil carcinoma patients. Acta Otolaryngol. 2008;128:583–9.CrossRefPubMed Cohen MA, Basha SR, Reichenbach DK, Robertson E, Sewell DA. Increased viral load correlates with improved survival in HPV-16 associated tonsil carcinoma patients. Acta Otolaryngol. 2008;128:583–9.CrossRefPubMed
17.
go back to reference Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122: 2656–64.CrossRefPubMed Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122: 2656–64.CrossRefPubMed
18.
go back to reference National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Used Data (1973–2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission. 2009. Available at: http://seer.cancer.gov. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program Public-Used Data (1973–2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission. 2009. Available at: http://​seer.​cancer.​gov.
19.
go back to reference Agresti A. Chapter 5: logistic regression. In: Categorical data analysis, 2nd ed. Hoboken, NJ: Wiley; 2002. p. 165–210. Agresti A. Chapter 5: logistic regression. In: Categorical data analysis, 2nd ed. Hoboken, NJ: Wiley; 2002. p. 165–210.
20.
go back to reference Kaplan E, und Meier P. Nonparametric estimation from incomplete Observations. J Am Stat Assoc. 1958;53:457–81.CrossRef Kaplan E, und Meier P. Nonparametric estimation from incomplete Observations. J Am Stat Assoc. 1958;53:457–81.CrossRef
21.
go back to reference Therneau TM, Grambsch PM. Chapter 3: the Cox model. In: Modeling survival data: extending the Cox model. New York: Springer-Verlag; 2000. p. 39–78. Therneau TM, Grambsch PM. Chapter 3: the Cox model. In: Modeling survival data: extending the Cox model. New York: Springer-Verlag; 2000. p. 39–78.
22.
go back to reference Tableman M, Kim JS. 2004. Survival analysis using S: analysis of time-to-event data. Boca Raton, FL: Chapman & Hall/CRC, pp. 95–180. Tableman M, Kim JS. 2004. Survival analysis using S: analysis of time-to-event data. Boca Raton, FL: Chapman & Hall/CRC, pp. 95–180.
24.
go back to reference Venables WN, Ripley BD. Modern Applied Statistics with S, 4th ed. New York: Springer-Verlag; 2002. p. 172–6. Venables WN, Ripley BD. Modern Applied Statistics with S, 4th ed. New York: Springer-Verlag; 2002. p. 172–6.
25.
go back to reference Manzoli L, Villari P, Pirone GM, Boccia A. Marital status and mortality in the elderly: A systemic review and meta-analysis. Soc Sci Med. 2007;64:77–94.CrossRefPubMed Manzoli L, Villari P, Pirone GM, Boccia A. Marital status and mortality in the elderly: A systemic review and meta-analysis. Soc Sci Med. 2007;64:77–94.CrossRefPubMed
26.
go back to reference Klussman JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162:747–53. Klussman JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol. 2003;162:747–53.
27.
go back to reference Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos G, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990;43:918–21.CrossRefPubMed Niedobitek G, Pitteroff S, Herbst H, Shepherd P, Finn T, Anagnostopoulos G, et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol. 1990;43:918–21.CrossRefPubMed
28.
go back to reference Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, et al. Squamous cell carcinoma of the tonsils: A molecular analysis of HPV association. Clin Cancer Res. 2002;8:1093–100.PubMed Strome SE, Savva A, Brissett AE, Gostout BS, Lewis J, Clayton AC, et al. Squamous cell carcinoma of the tonsils: A molecular analysis of HPV association. Clin Cancer Res. 2002;8:1093–100.PubMed
29.
go back to reference Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Q J Med. 2009; e publication. Nguyen NP, Chi A, Nguyen LM, Ly BH, Karlsson U, Vinh-Hung V. Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. Q J Med. 2009; e publication.
30.
go back to reference Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–9.CrossRefPubMed Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612–9.CrossRefPubMed
31.
go back to reference Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:429–35.CrossRef Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer. 2007;110:429–35.CrossRef
32.
go back to reference Zhang HS, Postigo AA, Dean DC. Active transcription repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGF beta, and contact inhibition. Cell. 1999;97:53–61.CrossRefPubMed Zhang HS, Postigo AA, Dean DC. Active transcription repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGF beta, and contact inhibition. Cell. 1999;97:53–61.CrossRefPubMed
33.
go back to reference Kumar B, Cordell KG, Lee JS, Worden HP, Prince ME, Tran HH, et al. EGFR, p16, HPV titer, Bcl-Xl and p53, sex, and smoking are indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128–37.CrossRefPubMed Kumar B, Cordell KG, Lee JS, Worden HP, Prince ME, Tran HH, et al. EGFR, p16, HPV titer, Bcl-Xl and p53, sex, and smoking are indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26:3128–37.CrossRefPubMed
34.
go back to reference Dahlstrand HM, Lindquist D, Bjornestal L, Ohlsson A, Dalianis T, Munck- Wikland E, et al. P16 correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res. 2005;25:4375–84. Dahlstrand HM, Lindquist D, Bjornestal L, Ohlsson A, Dalianis T, Munck- Wikland E, et al. P16 correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res. 2005;25:4375–84.
35.
go back to reference Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736–47.CrossRefPubMed Weinberger PM, Yu Z, Haffty BG, Kowalski D, Harigopal M, Brandsma J, et al. Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006;24:736–47.CrossRefPubMed
36.
go back to reference Hafkamp HC, Mooren JJ, Claessen SMH, Klingenberg B, Voogd AC, Bot FJ, et al. P21 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol. 2009;22:686–98.CrossRefPubMed Hafkamp HC, Mooren JJ, Claessen SMH, Klingenberg B, Voogd AC, Bot FJ, et al. P21 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol. 2009;22:686–98.CrossRefPubMed
37.
go back to reference Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human Papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:366–9.CrossRefPubMed Westra WH, Taube JM, Poeta ML, Begum S, Sidransky D, Koch WM. Inverse relationship between human Papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2008;14:366–9.CrossRefPubMed
38.
go back to reference Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous cell carcinoma of the head and neck. N Eng J Med. 2007;357:2552–661.CrossRef Poeta ML, Manola J, Goldwasser MA, Forastiere A, Benoit N, Califano JA, et al. TP53 mutations and survival in squamous cell carcinoma of the head and neck. N Eng J Med. 2007;357:2552–661.CrossRef
39.
go back to reference Chien CY, Su CY, Fang FM, Huang HY, Chuang HC, Chen CM, et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008;44:174–9.CrossRefPubMed Chien CY, Su CY, Fang FM, Huang HY, Chuang HC, Chen CM, et al. Lower prevalence but favorable survival for human papillomavirus-related squamous cell carcinoma of tonsil in Taiwan. Oral Oncol. 2008;44:174–9.CrossRefPubMed
40.
go back to reference Mellin H, Friesland S, Lewensohn R, Dallanis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.CrossRefPubMed Mellin H, Friesland S, Lewensohn R, Dallanis T, Munck-Wikland E. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer. 2000;89:300–4.CrossRefPubMed
41.
go back to reference Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival. Clin Cancer Res. 1996;2:755–62.PubMed Haraf DJ, Nodzenski E, Brachman D, Mick R, Montag A, Weichselbaum RR. Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival. Clin Cancer Res. 1996;2:755–62.PubMed
42.
go back to reference Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindhom J, et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol. 2007;1:350–5.CrossRefPubMed Lindquist D, Romanitan M, Hammarstedt L, Nasman A, Dahlstrand H, Lindhom J, et al. Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol. 2007;1:350–5.CrossRefPubMed
Metadata
Title
Importance of Age as a Prognostic Factor for Tonsillar Carcinoma
Authors
Nam P. Nguyen, MD
Bevan Hong Ly, MD
Michael Betz, MD
Vincent Vinh-Hung, MD
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 10/2010
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1167-0

Other articles of this Issue 10/2010

Annals of Surgical Oncology 10/2010 Go to the issue